Methylphenidate

Key figures

PRESCRIBERS
Main prescribers: Psychiatry	43.72%
INSURED CONSUMERS
% of insured consumers	2.18%
Median age	13 years
Max/min ratio of the median age (by district)	1.08
Percentage of women	26.38%
Ratio Preferential scheme/General scheme	0.77
Coefficient of variation (2023)	53.08
Max/min ratio of % of insured consumers (by district)	7.44
CONSUMPTION
Annual consumption (DDD)	5,741,119
Consumption of DDD (per 100,000 insured persons)	361,664.67
% DDD issued outside the insurance (approximate)	NA
Average annual consumption per insured consumer (DDD)	165.75
% of insured consumers with > 3 times the average consumption	3,35%
Coefficient of variation 2013-2015	60.82
Coefficient of variation 2021-2023	62.98
Trend 2013-2023	1.82%
Trend 2013-2021	2.09%
Trend 2021-2023	0.73%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance	5,129,270 €
Average annual expenditure per insured person	3.23 €
Average patient share per insured consumer	20.20%
Max/min ratio of expenditure per insured person (by disctrict)	12.96
% “Low-cost” medication	NA
Trend 2013-2023	-0.86%
Trend 2021-2023	2.00%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on a yellow background, otherwise on a grey background.